Attenuation of a delayed increase in the extracellular glutamate level in the peri-infarct area following focal cerebral ischemia by a novel agent ONO-2506

Neurochemistry International

Volumn 45, Issue 2-3, 2004, Pages 381-387

  Mori, Takashi ^a   Tateishi, Narito ^b   Kagamiishi, Yoshifumi ^b   Shimoda, Taiji ^b   Satoh, Souichi ^b   Ono, Sakiko ^b   Katsube, Nobuo ^b   Asano, Takao ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b ONO PHARMACEUTICAL CO   (Japan)

Author keywords

Extracellular glutamate; Focal cerebral ischemia; Microdialysis; Rat

Indexed keywords

ARUNDIC ACID; GLUTAMIC ACID; OCTANOIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN INFARCTION; BRAIN ISCHEMIA; CONTROLLED STUDY; MALE; MICRODIALYSIS; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION; SYMPTOMATOLOGY;

ANIMALS; CEREBRAL CORTEX; EXTRACELLULAR SPACE; GLUTAMIC ACID; ISCHEMIC ATTACK, TRANSIENT; KINETICS; MICRODIALYSIS; OCTANOIC ACIDS; RATS; RATS, WISTAR; REFERENCE VALUES;

EID: 2442629711     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2003.06.001     Document Type: Article

References (30)

1. Asano T., Matsui T., Morikawa E., Tateishi N., Kagamiishi Y., Satoh S., Kondo K. The ameliorative effect of ONO-2506 on the delayed and prolonged expansion of the infarct volume following permanent middle cerebral artery occlusion in rats. J. Cereb. Blood Flow Metab. 119(Suppl. 1):1999;S64
2. Beaulieu C., de Crespigny A., Tong D.C., Moseley M.E., Albers G.W., Marks M.P. Longitudinal magnetic resonance imaging study of perfusion and diffusion in stroke: Evolution of lesion volume and correlation with clinical outcome. Ann. Neurol. 46:1999;568-578
3. Benveniste H., Drejer J., Schousboe A., Diemer N.H. Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J. Neurochem. 43:1984;1369-1374
4. Choi D.W. Glutamate neurotoxicity and diseases of the nervous system. Neuron. 1:1988;623-634
5. Chow J., Orenberg J.B., Nugent K.D. Comparison of automated pre-column and post-column analysis of amino acid oligomers. J. Chromatogr. 386:1987;243-249
6. Du C., Hu R., Csernansky C.A., Hsu C.Y., Choi D.W. Very delayed infarction after mild focal cerebral ischemia: A role for apoptosis? J. Cereb. Blood Flow Metab. 16:1996;195-201
7. Eddleston M., Mucke L. Molecular profile of reactive astrocytes- implications for their role in neurologic disease. Neuroscience. 54:1993;15-36
8. Enblad P., Frykholm P., Valtysson J., Silander H.C., Andersson J., Fasth K.J., Watanabe Y., Långström B., Hillered L., Persson L. Middle cerebral artery occlusion and reperfusion in primates monitored by microdialysis and sequential positron emission tomography. Stroke. 32:2001;1574-1580
9. Griffin W.S., Sheng J.G., Royston M.C., Gentleman S.M., McKenzie J.E., Graham D.I., Roberts G.W., Mrak R.E. Glial-neuronal interactions in Alzheimer's disease: The potential role of a 'cytokine cycle' in disease progression. Brain Pathol. 8:1998;65-72
10. Haydon P.G. GLIA: Listening and talking to the synapse. Nat. Rev. Neurosci. 2:2001;185-193
11. Hu J., Ferreira A., Van Eldik L.J. S100β induces neuronal cell death through nitric oxide release from astrocytes. J. Neurochem. 69:1997;2294-2301
12. Hu J., Akama K.T., Krafft G.A., Chromy B.A., Van Eldik L.J. Amyloid-β peptide activates cultured astrocytes: Morphological alterations, cytokine induction and nitric oxide release. Brain Res. 785:1998;195-206
13. Lam A.G., Koppal T., Akama K.T., Guo L., Craft J.M., Samy B., Schavocky J.P., Watterson D.M., Van Eldik L.J. Mechanism of glial activation by S100B: Involvement of the transcription factor NFκB. Neurobiol. Aging. 22:2001;765-772
14. +-dependent glutamate transport. J. Neurosci. 19:1999;1-9
15. Matsui T., Mori T., Tateishi N., Kagamiishi Y., Satoh S., Katsube N., Morikawa E., Morimoto T., Ikuta F., Asano T. Astrocytic activation and delayed infarct expansion after permanent focal ischemia in rats. Part I: Enhanced astrocytic synthesis of S-100β in the periinfarct area precedes delayed infarct expansion. J. Cereb. Blood Flow Metab. 22:2002;711-722
16. Matsumoto K., Lo E.H., Pierce A.R., Halpern E.F., Newcomb R. Secondary elevation of extracellular neurotransmitter amino acids in the reperfusion phase following focal cerebral ischemia. J. Cereb. Blood Flow Metab. 16:1996;114-124
17. Mori T., Asano T., Matsui T., Muramatsu H., Ueda M., Kamiya T., Katayama Y., Abe T. Intraluminal increase of superoxide anion following transient focal cerebral ischemia in rats. Brain Res. 816:1999;350-357
18. Olney J.W. Excitatory transmitter neurotoxicity. Neurobiol. Aging. 15:1994;259-260
19. Rossi D.J., Oshima T., Attwell D. Glutamate release in severe brain ischaemia is mainly by reversed uptake. Nature. 403:2000;316-321
20. Shimoda T., Tateishi N., Shintaku K., Yada N., Katagi J., Akiyama T., Maekawa H., Shinagawa R., Kondo K. ONO-2506, a novel astrocyte modulating agent, suppresses the increase of COX-2 and iNOS mRNA expression in cultured astrocytes and ischemic brain. Soc. Neurosci. Abstr. 24:1998;384.13
21. Shinagawa R., Tateishi N., Shimoda T., Shintaku K., Yada N., Honjo K., Kagamiishi Y., Kondo K. ONO-2506 ameliorates neurodegeneration through inhibition of reduction of GLT-1 expression. Soc. Neurosci. Abstr. 24:1998;384.14
22. Shinagawa R., Tateishi N., Shimoda T., Maekawa H., Yada N., Akiyama T., Matsuda S., Katsube N. Modulating effects of ONO-2506 on astrocytic activation in cultured astrocytes from rat cerebrum. Soc. Neurosci. Abstr. 25:1999;843.10
23. Taguchi J., Graf R., Rosner G., Heiss W.D. Prolonged transient ischemia results in impaired CBF recovery and secondary glutamate accumulation in cats. J. Cereb. Blood Flow Metab. 16:1996;271-279
24. Takagi K., Ginsberg M.D., Globus M.Y., Dietrich W.D., Martinez E., Kraydieh S., Busto R. Changes in amino acid neurotransmitters and cerebral blood flow in the ischemic penumbral region following middle cerebral artery occlusion in the rat: Correlation with histopathology. J. Cereb. Blood Flow Metab. 13:1993;575-585
25. Tateishi N., Kagamiishi Y., Shintaku K., Shimoda T., Shinagawa R., Satoh S., Kondo K. Activation of astrocytes and ischemic damage following the transient focal ischemia. Folia. Pharmacol. Jan. 112:1998;103-107
26. Tateishi N., Mori T., Kagamiishi Y., Satoh S., Katsube N., Morikawa E., Morimoto T., Matsui T., Asano T. Astrocytic activation and delayed infarct expansion after permanent focal ischemia in rats. Part II: Suppression of astrocytic activation by a novel agent (R)-(-)-2-propyloctanoic acid (ONO-2506) leads to mitigation of delayed infarct expansion and early improvement of neurologic deficits. J. Cereb. Blood Flow Metab. 22:2002;723-734
27. Volterra A., Trotti D., Tromba C., Floridi S., Racagni G. Glutamate uptake inhibition by oxygen free radicals in rat cortical astrocytes. J. Neurosci. 14:1994;2924-2932
28. Witte O.W., Bidmon H.J., Schiene K., Redecker C., Hagemann G. Functional differentiation of multiple perilesional zones after focal cerebral ischemia. J. Cereb. Blood Flow Metab. 20:2000;1149-1165
29. Yamamoto M., Tamura A., Kirino T., Shimizu M., Sano K. Behavioral changes after focal cerebral ischemia by left middle cerebral artery occlusion in rats. Brain Res. 452:1988;323-328
30. Yue J.L., Nakamura S., Ueda H., Misu Y. Endogenously released L-DOPA itself tonically functions to potentiate postsynaptic D2 receptor-mediated locomotor activities of conscious rats. Neurosci. Lett. 28:1994;107-110